Fetal monkey surfactants after intra-amniotic or maternal administration of betamethasone and thyroid hormone

被引:18
作者
Gilbert, WM
Eby-Wilkens, E
Plopper, C
Whitsett, JA
Tarantal, AF
机构
[1] Univ Calif Davis, Dept Obstet & Gynecol, Sacramento, CA 95817 USA
[2] Univ Calif Davis, Dept Pediat, Sacramento, CA 95817 USA
[3] Univ Calif Davis, Dept Physiol, Sacramento, CA 95817 USA
[4] Univ Calif Davis, Calif Reg Primate Res Ctr, Sacramento, CA 95817 USA
[5] Childrens Hosp, Div Pulm Biol & Neonatol, Cincinnati, OH USA
关键词
D O I
10.1016/S0029-7844(01)01417-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To compare direct intra-amniotic injection of betamethasone and thyroxine (T4) with maternal treatment and controls for accelerating pulmonary surfactant production. METHODS: Twelve pregnant monkeys (Macaca mulatta) on gestational day 125 (term 165 +/- 10 days) had surfactant protein A and B concentrations measured in amniotic fluid. In four controls, normal saline was injected into the amniotic fluid; four others (intra-amniotic) received intraamniotic betamethasone (1 mg) and T4 (60 mug); and in four others (maternal), the dam was given betamethasone (12 mg) intramuscularly, repeated in 24 hours, plus = (400 mug) intravenously, repeated every 6 hours for 24 hours. Seventy-two hours after the initial amniocentesis, a hysterotomy was performed and fetal tissue and amniotic fluid harvested for determination of surfactant protein A and B concentrations and immunohistochemical staining for surfactant protein A. RESULTS: Amniotic fluid surfactant protein A was higher,with intra-amniotic injection than with maternal treatment (P < .04) or controls (P = .07). Amniotic fluid surfactant protein B was higher in the intra-amniotic group than in controls (P = .06). Immunohistochemical. staining for surfactant protein A in the lung tissue was increased in the intra-amniotic group compared with controls (0.145 +/- 0.01 versus 0.097 +/- 0.001, percent positive staining for surfactant protein A cells per lung tissue cells; P < .03). Birth weight was greater in the intra-amniotic group compared with the maternal group (P < .03) although not different from the controls. Finally, gut motility and the presence of formed meconium were increased in the intra-amniotic group compared with the other groups (P < .05). CONCLUSION: Intra-amniotic injection of betamethasone and T4 enhanced lung (and possibly intestinal) maturation of the preterm rhesus fetal monkey compared with maternal injections. (C) 2001 by the American College of Obstetricians and Gynecologists.
引用
收藏
页码:466 / 470
页数:5
相关论文
共 24 条
[1]   Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants [J].
Ballard, RA ;
Ballard, PL ;
Cnaan, A ;
Pinto-Martin, J ;
Davis, DJ ;
Padbury, JF ;
Phibbs, RH ;
Parer, JT ;
Hart, MC ;
Mannino, FL ;
Sawai, SK .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (08) :493-498
[2]   RESPIRATORY-DISEASE IN VERY-LOW-BIRTH-WEIGHT INFANTS AFTER PRENATAL THYROTROPIN-RELEASING-HORMONE AND GLUCOCORTICOID [J].
BALLARD, RA ;
BALLARD, PL ;
CREASY, RK ;
PADBURY, J ;
POLK, DH ;
BRACKEN, M ;
MOYA, FR ;
GROSS, I .
LANCET, 1992, 339 (8792) :510-515
[3]   THE EFFECTS OF CORTICOSTEROID ADMINISTRATION BEFORE PRETERM DELIVERY - AN OVERVIEW OF THE EVIDENCE FROM CONTROLLED TRIALS [J].
CROWLEY, P ;
CHALMERS, I ;
KEIRSE, MJNC .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (01) :11-25
[4]   Direct fetal glucocorticoid treatment alters postnatal adaptation in premature newborn baboons [J].
Ervin, MG ;
Seidner, SR ;
Leland, MM ;
Ikegami, M ;
Jobe, AH .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1998, 274 (04) :R1169-R1176
[5]   A REVIEW OF PREMATURE BIRTH AND SUBCLINICAL INFECTION [J].
GIBBS, RS ;
ROMERO, R ;
HILLIER, SL ;
ESCHENBACH, DA ;
SWEET, RL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (05) :1515-1528
[6]   The missing link in rhesus monkey amniotic fluid volume regulation: Intramembranous absorption [J].
Gilbert, WM ;
EbyWilkens, E ;
Tarantal, AF .
OBSTETRICS AND GYNECOLOGY, 1997, 89 (03) :462-465
[7]  
GILBERT WM, 1989, OBSTET GYNECOL, V74, P748
[8]   POTENTIAL ROUTE FOR FETAL THERAPY - INTRAMEMBRANOUS ABSORPTION OF INTRAAMNIOTICALLY INJECTED FUROSEMIDE [J].
GILBERT, WM ;
NEWMAN, PS ;
BRACE, RA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (05) :1471-1476
[9]   EFFECT OF CORTICOSTEROIDS FOR FETAL MATURATION ON PERINATAL OUTCOMES [J].
GILSTRAP, LC ;
CHRISTENSEN, R ;
CLEWELL, WH ;
DALTON, ME ;
DAVIDSON, EC ;
ESCOBEDO, MB ;
GJERDINGEN, DK ;
GODDARDFINEGOLD, J ;
GOLDENBERG, RK ;
GRIMES, DA ;
HANSEN, TN ;
KAUFFMAN, RE ;
KEELER, EB ;
OH, W ;
SUSMAN, EJ ;
VOGEL, MG ;
AVERY, ME ;
BALLARD, PL ;
BALLARD, RA ;
CROWLEY, P ;
GARITE, T ;
GOLDENBERG, RL ;
HANKINS, GDV ;
JOBE, AH ;
KOPPE, JG ;
MAHER, JE ;
MERKATZ, IR ;
SHANKARAN, S ;
SIMPSON, KN ;
SINCLAIR, JC ;
SLOTKIN, TA ;
TAEUSCH, HW ;
WRIGHT, LL ;
ALEXANDER, D ;
BERBERICH, MA ;
BRACKEN, M ;
COOPER, L ;
CULPEPPER, L ;
ELLIOTT, JM ;
FERGUSON, JH ;
FRIGOLETTO, F ;
GAIL, DB ;
HALL, WH ;
JONES, MD ;
MEDOFFCOOPER, B ;
MERENSTEIN, GB ;
WHALEN, JM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (05) :413-418
[10]  
HAVEOPBROEK AAW, 1992, ANAT REC, V234, P93